AstraZeneca PLC is 28.3x more valuable than Summit Therapeutics Inc. by market capitalization ($286.27 B vs $10.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SMMT | AZN |
|---|---|---|
| Market cap | $10.13 B | $286.27 B |
| US-listed rank | #935 | #45 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$1.08B | - |
| SEC filings | 532 | 1,004 |
AstraZeneca PLC is 28.3x more valuable than Summit Therapeutics Inc. by market capitalization ($286.27 B vs $10.13 B).
Full pages: Summit Therapeutics Inc. and AstraZeneca PLC, or browse the full rankings.